tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Revvity Inc

RVTY
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
112.904USD
+7.274+6.89%
์‹œ์žฅ ์šด์˜ ์‹œ๊ฐ„ย ๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
12.68B์‹œ๊ฐ€์ด์•ก
54.23P/E TTM

TradingKey Revvity Inc ์ฃผ์‹ ์ ์ˆ˜

ํ†ตํ™”: USD ๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: 2026-06-24

์ฃผ์š” ์ธ์‚ฌ์ดํŠธ

Revvity Inc์˜ ํŽ€๋”๋ฉ˜ํ„ธ์€ ๋น„๊ต์  ๊ฑด์ „ํ•œ ์ƒํƒœ์ด๋ฉฐ, ์„ฑ์žฅ ์ž ์žฌ๋ ฅ์€ ๋†’์Šต๋‹ˆ๋‹ค.๊ธฐ์—…์˜ ๋ฐธ๋ฅ˜์—์ด์…˜์€ ์ ์ •ํ•˜๊ฒŒ ํ‰๊ฐ€๋œ ๊ฒƒ์œผ๋กœ ๊ฐ„์ฃผ๋˜๋ฉฐ, ์˜๋ฃŒ ์žฅ๋น„ ๋ฐ ๊ณต๊ธ‰ํ’ˆ ์‚ฐ์—…์—์„œ 204๊ฐœ ์ค‘ 30์œ„ ๋žญํ‚น.๊ธฐ๊ด€ ๋ณด์œ  ๋น„์œจ์€ ๋งค์šฐ ๋†’์€.์ง€๋‚œ ํ•œ ๋‹ฌ ๋™์•ˆ ์—ฌ๋Ÿฌ ์• ๋„๋ฆฌ์ŠคํŠธ๊ฐ€ ํ•ด๋‹น ๊ธฐ์—…์„ ๋งค์ˆ˜(์œผ)๋กœ ํ‰๊ฐ€ํ–ˆ์œผ๋ฉฐ, ์ตœ๊ณ  ๋ชฉํ‘œ ๊ฐ€๊ฒฉ์€ 115.44์ž…๋‹ˆ๋‹ค.์ค‘๊ธฐ์ ์œผ๋กœ ์ฃผ๊ฐ€๋Š” ์ƒ์Šน ์ถ”์„ธ์ผ ๊ฒƒ์œผ๋กœ ์˜ˆ์ƒ๋ฉ๋‹ˆ๋‹ค.๊ธฐ์—…์€ ์ง€๋‚œ ํ•œ ๋‹ฌ๊ฐ„ ์ฃผ์‹ ์‹œ์žฅ์—์„œ ์–‘ํ˜ธํ•œ ์„ฑ๊ณผ๋ฅผ ๊ฑฐ๋‘์—ˆ์œผ๋ฉฐ, ํƒ„ํƒ„ํ•œ ํŽ€๋”๋ฉ˜ํ„ธ๊ณผ ๊ธฐ์ˆ ์  ์ง€ํ‘œ๊ฐ€ ์ด๋ฅผ ๋’ท๋ฐ›์นจํ•˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค.์ฃผ๊ฐ€๋Š” ์ง€์ง€์„ ๊ณผ ์ €ํ•ญ์„  ์‚ฌ์ด์—์„œ ํšก๋ณดํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ๋ฒ”์œ„ ๋งค๋งค ๊ธฐ๋ฐ˜์˜ ์Šค์œ™ ํŠธ๋ ˆ์ด๋”ฉ์— ์ ํ•ฉํ•œ ์ƒํ™ฉ์ž…๋‹ˆ๋‹ค.

Revvity Inc ์ ์ˆ˜๎˜ฐ๎˜ฐ

๊ด€๋ จ ์ •๋ณด

์‚ฐ์—… ์ˆœ์œ„
30 / 204
์ „์ฒด ์ˆœ์œ„
87 / 4571
์‚ฐ์—…
์˜๋ฃŒ ์žฅ๋น„ ๋ฐ ๊ณต๊ธ‰ํ’ˆ

์ €ํ•ญ์„  & ์ง€์ง€์„ 

๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.

๋ ˆ์ด๋” ์ฐจํŠธ

ํ˜„์žฌ ๊ฐ€๊ฒฉ
๊ณผ๊ฑฐ

๋ฏธ๋””์–ด ๋ณด๋„

์ตœ๊ทผ 24 ์‹œ๊ฐ„
๋ณด๋„ ์ˆ˜์ค€

๋งค์šฐ ๋‚ฎ์€
๋งค์šฐ ๋†’์€
๋ถ€์ •-

Revvity Inc ์ฃผ์š” ๋‚ด์šฉ

๊ฐ•์ ์œ„ํ—˜ ์š”์†Œ
Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.
๋†’์€ ๋ฐฐ๋‹น๊ธˆ
ํšŒ์‚ฌ๋Š” ๋†’์€ ๋ฐฐ๋‹น๊ธˆ์„ ์ง€๊ธ‰ํ•˜๋Š” ํšŒ์‚ฌ๋กœ, ์ตœ์‹  ๋ฐฐ๋‹น๊ธˆ ์ง€๊ธ‰ ๋น„์œจ์€ 12.14%์ž…๋‹ˆ๋‹ค.
์•ˆ์ •์ ์ธ ๋ฐฐ๋‹น๊ธˆ
ํšŒ์‚ฌ๋Š” ์ง€๋‚œ 5๋…„ ๋™์•ˆ ์ •๊ธฐ์ ์œผ๋กœ ๋ฐฐ๋‹น๊ธˆ์„ ์ง€๊ธ‰ํ•˜์˜€์œผ๋ฉฐ, ์ตœ์‹  ๋ฐฐ๋‹น๊ธˆ ์ง€๊ธ‰ ๋น„์œจ์€ 12.14%์ž…๋‹ˆ๋‹ค.
๊ณต์ •ํ•œ ๊ฐ€์น˜
ํšŒ์‚ฌ์˜ ์ตœ์‹  PE์€ 50.73๋กœ, ์ตœ๊ทผ 3๋…„ ๊ธฐ์ค€ ์ค‘๊ฐ„ ๋ฐฑ๋ถ„์œ„ ๋ฒ”์œ„์— ์†ํ•ฉ๋‹ˆ๋‹ค.
๊ธฐ๊ด€ ๋งค๋„
์ตœ์‹  ๊ธฐ๊ด€ ๋ณด์œ  ์ฃผ์‹ ์ˆ˜๋Š” 116.42M์ฃผ์ด๋ฉฐ, ์ „ ๋ถ„๊ธฐ ๋Œ€๋น„ 9.50% ๊ฐ์†Œํ–ˆ์Šต๋‹ˆ๋‹ค.
EDGEPOINT CANADIAN PORTFOLIO๊ฐ€ ๋ณด์œ 
์Šคํƒ€ ํˆฌ์ž์ž EDGEPOINT CANADIAN PORTFOLIO์ด(๊ฐ€) ์ด ์ฃผ์‹ 7.96M์ฃผ๋ฅผ ๋ณด์œ ํ•˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค.

๋ถ„์„๊ฐ€ ๋ชฉํ‘œ๊ฐ€

18 ๋ช…์˜ ๋ถ„์„๊ฐ€๋ฅผ ๊ธฐ์ค€์œผ๋กœ
๋งค์ˆ˜
ํ˜„์žฌ ๋“ฑ๊ธ‰
115.437
๋ชฉํ‘œ ๊ฐ€๊ฒฉ
+15.44%
์ƒ์Šน ์—ฌ๋ ฅ
๋ฉด์ฑ… ์กฐํ•ญ: ์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€ ๋ฐ ๋ชฉํ‘œ ์ฃผ๊ฐ€๋Š” ์ •๋ณด ์ œ๊ณต์„ ์œ„ํ•œ ๋ชฉ์ ์œผ๋กœ LSEG์—์„œ ์ œ๊ณต๋˜๋ฉฐ, ํˆฌ์ž ์กฐ์–ธ์œผ๋กœ ๊ฐ„์ฃผ๋˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.

์œ ์‚ฌ ์ข…๋ชฉ
๎˜ฐ๎˜ฐ

์˜๋ฃŒ ์žฅ๋น„ ๋ฐ ๊ณต๊ธ‰ํ’ˆ
๎™
Revvity Inc
Revvity Inc
RVTY
8.21 /10
์ฃผ์‹ ์ ์ˆ˜
์žฌ๋ฌด ๊ฑด์ „์„ฑ
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc
TMO
9.07 /10
์ฃผ์‹ ์ ์ˆ˜
์žฌ๋ฌด ๊ฑด์ „์„ฑ
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
Cencora Inc
Cencora Inc
COR
8.86 /10
์ฃผ์‹ ์ ์ˆ˜
์žฌ๋ฌด ๊ฑด์ „์„ฑ
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
Glaukos Corp
Glaukos Corp
GKOS
8.77 /10
์ฃผ์‹ ์ ์ˆ˜
์žฌ๋ฌด ๊ฑด์ „์„ฑ
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
iRhythm Technologies Inc
iRhythm Technologies Inc
IRTC
8.71 /10
์ฃผ์‹ ์ ์ˆ˜
์žฌ๋ฌด ๊ฑด์ „์„ฑ
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
WST
8.67 /10
์ฃผ์‹ ์ ์ˆ˜
์žฌ๋ฌด ๊ฑด์ „์„ฑ
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
๋” ๋ณด๊ธฐ

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

TradingKey๋Š” ์–ด๋–ค ๋ฐฉ์‹์œผ๋กœ Revvity Inc์˜ ์ฃผ์‹ ์ ์ˆ˜๋ฅผ ์ƒ์„ฑํ•˜๋‚˜์š”?

๎™Œ
TradingKey ์ฃผ์‹ ์ ์ˆ˜๋Š” 100๊ฐœ ์ด์ƒ์˜ ๊ธฐ์ดˆ ๋ฐ์ดํ„ฐ ํฌ์ธํŠธ์—์„œ ๋„์ถœ๋œ 34๊ฐœ์˜ ์ง€ํ‘œ๋ฅผ ๊ธฐ๋ฐ˜์œผ๋กœ Revvity Inc์— ๋Œ€ํ•œ ์ข…ํ•ฉ ํ‰๊ฐ€๋ฅผ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค.
์ด ์ง€ํ‘œ๋“ค์€ ์žฌ๋ฌด ๊ฑด์ „์„ฑ, ํšŒ์‚ฌ ๊ฐœ์š”, ์ˆ˜์ต ์˜ˆ์ƒ, ๊ฐ€๊ฒฉ ๋ชจ๋ฉ˜ํ…€, ๊ธฐ๊ด€ ์‹ ๋ขฐ, ๋ฆฌ์Šคํฌ ํ‰๊ฐ€์˜ ์—ฌ์„ฏ ๊ฐ€์ง€ ํ•ต์‹ฌ ์ฐจ์›์œผ๋กœ ๋ถ„๋ฅ˜๋˜๋ฉฐ, ์ด๋“ค์€ ํ•จ๊ป˜ Revvity Inc์˜ ์„ฑ๊ณผ์™€ ์ „๋ง์— ๋Œ€ํ•œ ์ฒ ์ €ํ•œ ๋ถ„์„์„ ํˆฌ์ž์ž์—๊ฒŒ ์ œ์‹œํ•ฉ๋‹ˆ๋‹ค.

Revvity Inc์˜ ์žฌ๋ฌด ๊ฑด์ „์„ฑ ์ ์ˆ˜๋Š” ์–ด๋–ป๊ฒŒ ์ƒ์„ฑ๋˜๋‚˜์š”?

๎™Œ
Revvity Inc์˜ ์žฌ๋ฌด ๊ฑด์ „์„ฑ ์ ์ˆ˜๋ฅผ ์‚ฐ์ถœํ•˜๊ธฐ ์œ„ํ•ด์„œ๋Š” ์žฌ๋ฌด ํŽ€๋”๋ฉ˜ํ„ธ, ์ˆ˜์ต ํ’ˆ์งˆ, ์šด์˜ ํšจ์œจ์„ฑ, ์„ฑ์žฅ ์ž ์žฌ๋ ฅ, ์ฃผ์ฃผ ์ˆ˜์ต ๋“ฑ์˜ ํ•ต์‹ฌ ์ฐจ์›์„ ๊ธฐ๋ฐ˜์œผ๋กœ ๋‹ค์–‘ํ•œ ์ฃผ์š” ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ๋ถ„์„ํ•ฉ๋‹ˆ๋‹ค.
์ด๋Ÿฌํ•œ ์ข…ํ•ฉ ๋ฐ์ดํ„ฐ๋ฅผ ํ†ตํ•ฉํ•˜์—ฌ ๋„์ถœ๋œ ์žฌ๋ฌด ๊ฑด์ „์„ฑ ์ ์ˆ˜๋Š” Revvity Inc์˜ ์ „๋ฐ˜์ ์ธ ์•ˆ์ •์„ฑ, ์šด์˜ ํšจ์œจ์„ฑ, ์„ฑ์žฅ ์ž ์žฌ๋ ฅ๋ฟ๋งŒ ์•„๋‹ˆ๋ผ ์ฃผ์ฃผ์—๊ฒŒ ์ „๋‹ฌ๋˜๋Š” ์ˆ˜์ต๋„ ๋ฐ˜์˜ํ•ฉ๋‹ˆ๋‹ค. ์ด ์ ์ˆ˜๋Š” ํˆฌ์ž์ž ๋ฐ ๊ธฐํƒ€ ์ดํ•ด๊ด€๊ณ„์ž๊ฐ€ ํ•ฉ๋ฆฌ์ ์ธ ์˜์‚ฌ๊ฒฐ์ •์„ ๋‚ด๋ฆด ์ˆ˜ ์žˆ๋„๋ก ์ง€์›ํ•˜๋ฉฐ, ์ ์ˆ˜๊ฐ€ ๋†’์„์ˆ˜๋ก Revvity Inc์˜ ์žฌ๋ฌด ๊ฑด์ „์„ฑ์ด ์šฐ์ˆ˜ํ•จ์„ ์˜๋ฏธํ•ฉ๋‹ˆ๋‹ค.

Revvity Inc์˜ ๊ธฐ์—… ๊ฐ€์น˜ ์ ์ˆ˜๋Š” ์–ด๋–ป๊ฒŒ ์ƒ์„ฑ๋˜๋‚˜์š”?

๎™Œ
Revvity Inc์˜ ๊ธฐ์—… ๊ฐ€์น˜ํ‰๊ฐ€ ์ ์ˆ˜๋ฅผ ์‚ฐ์ถœํ•˜๊ธฐ ์œ„ํ•ด์„œ๋Š” ์ฃผ๊ฐ€์ˆ˜์ต๋น„์œจ(P/E), ์ฃผ๊ฐ€์ˆœ์ž์‚ฐ๋น„์œจ(P/B), ์ฃผ๊ฐ€๋งค์ถœ๋น„์œจ(P/S), ์ฃผ๊ฐ€ํ˜„๊ธˆํ๋ฆ„๋น„์œจ(P/CF) ๋“ฑ ๋‹ค์–‘ํ•œ ํ•ต์‹ฌ ์žฌ๋ฌด ๋น„์œจ์„ ์‚ฌ์šฉํ•ฉ๋‹ˆ๋‹ค. ์ด๋Ÿฌํ•œ ์ˆ˜์น˜๋Š” Revvity Inc์˜ ์‹œ์žฅ ๊ฐ€์น˜๋ฅผ ์ˆ˜์ต, ์ž์‚ฐ, ๋งค์ถœ ๋ฐ ํ˜„๊ธˆ ํ๋ฆ„๊ณผ ๋น„๊ตํ•˜์—ฌ ๊ธฐ์—… ๊ฐ€์น˜๋ฅผ ํ‰๊ฐ€ํ•˜๊ธฐ ์œ„ํ•œ ํ•ต์‹ฌ ์ง€ํ‘œ ์—ญํ• ์„ ํ•ฉ๋‹ˆ๋‹ค.
์ด๋Ÿฌํ•œ ๋น„์œจ๋“ค์„ ์ข…ํ•ฉ์ ์œผ๋กœ ๋ถ„์„ํ•จ์œผ๋กœ์จ, ๊ฐ€์น˜ํ‰๊ฐ€ ์ ์ˆ˜๋Š” ์‹œ์žฅ์ด ํ˜„์žฌ Revvity Inc์˜ ๊ฐ€์น˜๋ฅผ ์–ด๋–ป๊ฒŒ ์ธ์‹ํ•˜๊ณ  ์žˆ๋Š”์ง€๋ฟ๋งŒ ์•„๋‹ˆ๋ผ ๋ฏธ๋ž˜ ์ˆ˜์ต์„ฑ ๋ฐ ์„ฑ์žฅ ๊ฐ€๋Šฅ์„ฑ๊นŒ์ง€ ๋ฐ˜์˜ํ•˜์—ฌ ๋ณด๋‹ค ํ˜„๋ช…ํ•˜๊ฒŒ ํˆฌ์ž ๊ฒฐ์ •์„ ๋‚ด๋ฆด ์ˆ˜ ์žˆ๋„๋ก ์ง€์›ํ•ฉ๋‹ˆ๋‹ค. ์ ์ˆ˜๊ฐ€ ๋†’์„์ˆ˜๋ก Revvity Inc์˜ ๊ณต์ •๊ฐ€์น˜์— ๊ฐ€๊น๋‹ค๋Š” ์ ์„ ์˜๋ฏธํ•ฉ๋‹ˆ๋‹ค.

Revvity Inc์˜ ์ˆ˜์ต ์˜ˆ์ƒ ์ ์ˆ˜๋Š” ์–ด๋–ป๊ฒŒ ์ƒ์„ฑ๋˜๋‚˜์š”?

๎™Œ
Revvity Inc์˜ ์ˆ˜์ต ์˜ˆ์ƒ ์ ์ˆ˜๋ฅผ ์‚ฐ์ถœํ•˜๊ธฐ ์œ„ํ•ด ๋ถ„์„๊ฐ€ ํ‰๊ฐ€, ์žฌ๋ฌด ์˜ˆ์ƒ, ์ง€์ง€์„  ๋ฐ ์ €ํ•ญ์„ , ๊ทธ๋ฆฌ๊ณ  ์—…๊ณ„ ๋น„๊ต์™€ ๊ฐ™์€ ๋‹ค์–‘ํ•œ ํ•ต์‹ฌ ์ง€ํ‘œ๋ฅผ ๊ณ ๋ คํ•ฉ๋‹ˆ๋‹ค:
ํ˜„์žฌ ๋“ฑ๊ธ‰๊ณผ ๋ชฉํ‘œ ๊ฐ€๊ฒฉ์€ ๋ถ„์„๊ฐ€์˜ ๊ธฐ๋Œ€๋ฅผ ์ง์ ‘ ๋ฐ˜์˜ํ•˜๋ฉฐ, ์ƒ์Šน ์—ฌ๋ ฅ์€ ํ•ด๋‹น ์ฃผ์‹์˜ ์„ฑ์žฅ ์ž ์žฌ๋ ฅ์— ๋Œ€ํ•œ ๋ถ„์„๊ฐ€๋“ค์˜ ๋ณด๊ธฐ๋ฅผ ๋‚˜ํƒ€๋ƒ…๋‹ˆ๋‹ค.
์ฃผ๋‹น์ˆœ์ด์ต(EPS), ์ˆ˜์ต, ์ˆœ์ด์ต, ์ด์ž ๋ฐ ์„ธ๊ธˆ ์ฐจ๊ฐ ์ „ ์ด์ต(EBIT)๊ณผ ๊ฐ™์€ ์žฌ๋ฌด ์ง€ํ‘œ๋Š” ์ˆ˜์ต์„ฑ์„ ํ‰๊ฐ€ํ•˜๋Š” ํ•ต์‹ฌ ์ฒ™๋„์ž…๋‹ˆ๋‹ค.
๋ชฉํ‘œ ๊ฐ€๊ฒฉ์˜ ๊ณ ๊ฐ€, ์ค‘๊ฐ„๊ฐ’, ์ €๊ฐ€ ๊ฐ€๊ฒฉ ๋ฒ”์œ„๋ฅผ ๋ถ„์„ํ•จ์œผ๋กœ์จ, ๊ฐ€๊ฒฉ ์ถ”์„ธ๋ฅผ ํŒŒ์•…ํ•˜๊ณ  ํ•ต์‹ฌ ์ง€์ง€์„  ๋ฐ ์ €ํ•ญ์„ ์„ ์‹๋ณ„ํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
์ด๋Ÿฌํ•œ ์ง€ํ‘œ๋ฅผ ๋™์ข… ์—…๊ณ„์™€ ๋น„๊ตํ•จ์œผ๋กœ์จ ์ฃผ์‹์˜ ์„ฑ๊ณผ์— ๋Œ€ํ•œ ๋งฅ๋ฝ์„ ์ œ๊ณตํ•˜๊ณ  ๋ณด๋‹ค ํ˜„์‹ค์ ์ธ ์˜ˆ์ƒ ์„ค์ •์— ๋„์›€์ด ๋ฉ๋‹ˆ๋‹ค.
์ด๋Ÿฌํ•œ ์š”์†Œ๋“ค์€ ํ†ตํ•ฉ๋˜์–ด ์ฃผ์‹์˜ ์˜ˆ์ƒ ์žฌ๋ฌด ์‹ค์ ๊ณผ ์„ฑ์žฅ ์ž ์žฌ๋ ฅ์„ ์ •ํ™•ํ•˜๊ฒŒ ๋ฐ˜์˜ํ•˜๋Š” ์ข…ํ•ฉ์ ์ธ ์ˆ˜์ต ์˜ˆ์ƒ ์ ์ˆ˜๋ฅผ ๊ตฌ์„ฑํ•ฉ๋‹ˆ๋‹ค. ์ ์ˆ˜๊ฐ€ ๋†’์„์ˆ˜๋ก ๋ถ„์„๊ฐ€๋Š” Revvity Inc์˜ ๋ฏธ๋ž˜ ์ „๋ง์„ ๋” ๋‚™๊ด€์ ์œผ๋กœ ๋ณด๊ณ  ์žˆ์Œ์„ ์‹œ์‚ฌํ•ฉ๋‹ˆ๋‹ค.

Revvity Inc์˜ ๊ฐ€๊ฒฉ ๋ชจ๋ฉ˜ํ…€ ์ ์ˆ˜๋Š” ์–ด๋–ป๊ฒŒ ์ƒ์„ฑ๋˜๋‚˜์š”?

๎™Œ
Revvity Inc์˜ ๊ฐ€๊ฒฉ ๋ชจ๋ฉ˜ํ…€ ์ ์ˆ˜๋ฅผ ์‚ฐ์ถœํ•˜๊ธฐ ์œ„ํ•ด์„œ๋Š” ์ง€์ง€์„  ๋ฐ ์ €ํ•ญ์„ ๊ณผ ๊ฑฐ๋ž˜๋Ÿ‰ ์ˆ˜์น˜๋ฅผ ํฌํ•จํ•œ ๋ชจ๋ฉ˜ํ…€ ์ง€ํ‘œ๋ฅผ ๋ถ„์„ํ•ฉ๋‹ˆ๋‹ค.
์ง€์ง€์„ ์€ ๋งค์ˆ˜ ์ˆ˜์š”๊ฐ€ ์ปค์„œ ๊ฐ€๊ฒฉ ํ•˜๋ฝ์„ ๋ฐฉ์–ดํ•  ์ˆ˜ ์žˆ๋Š” ๊ฐ€๊ฒฉ ์ˆ˜์ค€์„ ์˜๋ฏธํ•˜๋ฉฐ, ์ €ํ•ญ์„ ์€ ๋งค๋„ ์••๋ ฅ์ด ์ฃผ๊ฐ€ ์ƒ์Šน์„ ๋ฐฉํ•ดํ•  ์ˆ˜ ์žˆ๋Š” ๊ฐ€๊ฒฉ ์ˆ˜์ค€์„ ์˜๋ฏธํ•ฉ๋‹ˆ๋‹ค. ์ผ๋ฐ˜์ ์ธ ๊ฐ€๊ฒฉ ๊ฑฐ๋ž˜๋Ÿ‰๊ณผ ์ด ๊ฑฐ๋ž˜๋Ÿ‰์„ ํ•จ๊ป˜ ๋ถ„์„ํ•จ์œผ๋กœ์จ ์‹œ์žฅ์—์„œ์˜ ์ „๋ฐ˜์ ์ธ ํ™œ๋™์„ฑ๊ณผ ์œ ๋™์„ฑ์„ ํ‰๊ฐ€ํ•ฉ๋‹ˆ๋‹ค. ์ด๋Ÿฌํ•œ ์ง€ํ‘œ๋Š” ๊ฐ€๊ฒฉ ์ถ”์„ธ์™€ ์ž ์žฌ์ ์ธ ๋ณ€ํ™”๋ฅผ ์‹๋ณ„ํ•˜๋Š” ๋ฐ ๋„์›€์„ ์ฃผ์–ด ํ–ฅํ›„ ์ˆ˜์ต์„ ๋ณด๋‹ค ์ •ํ™•ํ•˜๊ฒŒ ์˜ˆ์ธกํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
์ด์™€ ๊ฐ™์€ ์ข…ํ•ฉ์ ์ธ ๋ถ„์„์€ ์‹œ์žฅ ์‹ฌ๋ฆฌ๋ฅผ ๋ฐ˜์˜ํ•˜๊ณ  Revvity Inc์˜ ๊ฐ€๊ฒฉ์— ๋Œ€ํ•œ ํ•ฉ๋ฆฌ์ ์ธ ์˜ˆ์ƒ์„ ๊ฐ€๋Šฅํ•˜๊ฒŒ ํ•ฉ๋‹ˆ๋‹ค. ์ ์ˆ˜๊ฐ€ ๋†’์„์ˆ˜๋ก Revvity Inc์˜ ๋‹จ๊ธฐ ๊ฐ€๊ฒฉ ์ถ”์„ธ๊ฐ€ ๋” ์•ˆ์ •์ ์ž„์„ ๋‚˜ํƒ€๋ƒ…๋‹ˆ๋‹ค.

Revvity Inc์˜ ๊ธฐ๊ด€ ์‹ ๋ขฐ ์ ์ˆ˜๋Š” ์–ด๋–ป๊ฒŒ ์ƒ์„ฑ๋˜๋‚˜์š”?

๎™Œ
Revvity Inc์˜ ๊ธฐ๊ด€ ์‹ ๋ขฐ๋„ ์ ์ˆ˜๋ฅผ ์‚ฐ์ถœํ•˜๊ธฐ ์œ„ํ•ด์„œ๋Š” ๊ธฐ๊ด€์ด ๋ณด์œ ํ•œ ์ฃผ์‹์˜ ๋น„์œจ๊ณผ ๋ณด์œ  ์ฃผ์‹ ์ˆ˜๋ฅผ ๋ถ„์„ํ•ฉ๋‹ˆ๋‹ค. ๊ธฐ๊ด€ ๋ณด์œ  ๋น„์œจ์ด ๋†’์„์ˆ˜๋ก ์ „๋ฌธ ํˆฌ์ž์ž๋“ค์˜ ์‹ ๋ขฐ๋„๊ฐ€ ๋†’๋‹ค๋Š” ์ ์„ ์˜๋ฏธํ•˜๋ฉฐ, Revvity Inc์˜ ์ž ์žฌ๋ ฅ์— ๋Œ€ํ•œ ๊ฐ•์„ธ ์‹ ํ˜ธ๋กœ ํ•ด์„๋ฉ๋‹ˆ๋‹ค. ๊ธฐ๊ด€ ํˆฌ์ž์ž๋Š” ์ผ๋ฐ˜์ ์œผ๋กœ ์ฒ ์ €ํ•œ ๋ถ„์„์„ ์ˆ˜ํ–‰ํ•œ ์ดํ›„ ํˆฌ์ž ๊ฒฐ์ •์„ ๋‚ด๋ฆฌ๋ฏ€๋กœ ๊ธฐ๊ด€ ๋ณด์œ  ์ฃผ์‹ ์ˆ˜๋ฅผ ๋ถ„์„ํ•˜๋ฉด ํ•ด๋‹น ์ฃผ์‹์— ๋Œ€ํ•œ ๊ธฐ๊ด€์˜ ์˜์ง€์™€ ํƒœ๋„๋ฅผ ๋” ๊นŠ์ด ์ดํ•ดํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ๊ธฐ๊ด€ ์‹ ๋ขฐ๋„๋ฅผ ์ดํ•ดํ•˜๋ฉด ์ˆ˜์ต ์˜ˆ์ƒ์„ ๋ณด๋‹ค ์ •๊ตํ•˜๊ฒŒ ๋‹ค๋“ฌ๊ณ , ๊ธฐ์—…์˜ ํ–ฅํ›„ ์„ฑ๊ณผ ๋ฐ ์‹œ์žฅ ์•ˆ์ •์„ฑ์— ๋Œ€ํ•ด ๋” ์‹ ๋ขฐํ•  ์ˆ˜ ์žˆ๋Š” ์‹œ๊ฐ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ ์ˆ˜๊ฐ€ ๋†’์„์ˆ˜๋ก Revvity Inc์— ๋Œ€ํ•œ ๊ธฐ๊ด€์˜ ์ง€์ง€๋„๊ฐ€ ๋” ๋†’๋‹ค๋Š” ๊ฒƒ์„ ์˜๋ฏธํ•ฉ๋‹ˆ๋‹ค.

Revvity Inc์˜ ๋ฆฌ์Šคํฌ ๊ด€๋ฆฌ ์ ์ˆ˜๋Š” ์–ด๋–ป๊ฒŒ ์ƒ์„ฑ๋˜๋‚˜์š”?

๎™Œ
Revvity Inc์˜ ๋ฆฌ์Šคํฌ ๊ด€๋ฆฌ ์ ์ˆ˜๋ฅผ ํ‰๊ฐ€ํ•˜๊ธฐ ์œ„ํ•ด์„œ๋Š” ์ˆ˜์ต, ๋ฆฌ์Šคํฌ, ๋ณ€๋™์„ฑ ๋ฐ ์œ ๋™์„ฑ๊ณผ ๊ด€๋ จ๋œ ๋‹ค์–‘ํ•œ ์ฃผ์š” ์ง€ํ‘œ๋ฅผ ๋ถ„์„ํ•ฉ๋‹ˆ๋‹ค.
์ผ์ผ ์ตœ๊ณ  ๋ฐ ์ตœ์ € ์ˆ˜์ต๋ฅ ์€ ์ž ์žฌ์ ์ธ ์ด์ต๊ณผ ์†์‹ค์˜ ๊ทœ๋ชจ๋ฅผ ๋ฐ˜์˜ํ•˜๋ฉฐ, ์ƒคํ”„ ๋น„์œจ์€ ๋ฆฌ์Šคํฌ๋ฅผ ์กฐ์ •ํ•œ ์ˆ˜์ต ์„ฑ๊ณผ๋ฅผ ์ธก์ •ํ•ฉ๋‹ˆ๋‹ค. ๋ฆฌ์Šคํฌ ์ธก๋ฉด์—์„œ๋Š” ์ตœ๋Œ€ ์†์‹คํญ๊ณผ ์ˆ˜์ต ๋Œ€๋น„ ์†์‹คํญ ๋น„์œจ์„ ๋ถ„์„ํ•˜์—ฌ ๊ทน๋‹จ์ ์ธ ์†์‹ค ์‹œ๋‚˜๋ฆฌ์˜ค๋ฅผ ํŒŒ์•…ํ•ฉ๋‹ˆ๋‹ค. ์™œ๋„๋Š” ์ˆ˜์ต ๋ถ„ํฌ์™€ ์„ฑ๊ณผ์˜ ํŽธํ–ฅ ์—ฌ๋ถ€๋ฅผ ํ‰๊ฐ€ํ•˜๋Š” ๋ฐ ๋„์›€์ด ๋ฉ๋‹ˆ๋‹ค. ์‹คํ˜„ ๋ณ€๋™์„ฑ, ํ‘œ์ค€ํ™”๋œ ์‹ค์งˆ๊ฐ€๊ฒฉ๋ณ€๋™ํญ๊ณผ ๊ฐ™์€ ๋ณ€๋™์„ฑ ์ง€ํ‘œ๋Š” ๊ฐ€๊ฒฉ ๋ณ€๋™์„ ๋ณด์—ฌ์ค๋‹ˆ๋‹ค. ํ•˜๋ฐฉ ๋ฆฌ์Šคํฌ๋ฅผ ์กฐ์ •ํ•œ ์ˆ˜์ต์€ ์ž ์žฌ์ ์ธ ์†์‹ค๊ณผ ์ด์ต์— ๋Œ€ํ•œ ์ธ์‚ฌ์ดํŠธ๋ฅผ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ๋งˆ์ง€๋ง‰์œผ๋กœ, ํ‰๊ท  ๊ฑฐ๋ž˜๋Œ€๊ธˆ ๋ฐ ๊ฑฐ๋ž˜๋Œ€๊ธˆ ํŽธ์ฐจ์™€ ๊ฐ™์€ ์œ ๋™์„ฑ ์ง€ํ‘œ๋Š” ํ•ด๋‹น ์ฃผ์‹์˜ ๊ฑฐ๋ž˜ ํ™œ๋ฐœ์„ฑ์„ ๋‚˜ํƒ€๋ƒ…๋‹ˆ๋‹ค.
์ด๋Ÿฌํ•œ ์ง€ํ‘œ๋ฅผ ์ข…ํ•ฉ์ ์œผ๋กœ ๋ถ„์„ํ•˜๋ฉด Revvity Inc์˜ ๋ฆฌ์Šคํฌ-์ˆ˜์ต ํ”„๋กœํŒŒ์ผ์— ๋Œ€ํ•œ ๋‹ค์ฐจ์›์ ์ธ ์ดํ•ด๋ฅผ ์ œ๊ณตํ•˜๋ฉฐ, ์ด๋Š” ๋ฆฌ์Šคํฌ ๊ด€๋ฆฌ ์ ์ˆ˜์˜ ํ•ต์‹ฌ ์š”์†Œ๋กœ ์ž‘์šฉํ•ฉ๋‹ˆ๋‹ค. ์ ์ˆ˜๊ฐ€ ๋†’์„์ˆ˜๋ก Revvity Inc์˜ ๋ฆฌ์Šคํฌ๊ฐ€ ๋‚ฎ๋‹ค๋Š” ๊ฒƒ์„ ์˜๋ฏธํ•ฉ๋‹ˆ๋‹ค.
KeyAI
๎™